-- BMOは、マレン・グループ（MTL.TO）の株価目標を3.00ドル引き上げ23.00ドルとし、同社の見通しが明るくなったことを理由に「アウトパフォーム」の投資判断を維持した。 同社は第1四半期決算を発表し、予想通りの業績となったが、アナリストのジョン・ギブソン氏は、3月の貨物需要の回復は、マレンのトラック輸送および物流事業全般にとって好材料だと指摘している。 「さらに、アラスカLNGプロジェクトやカナダでの国家建設プロジェクトなど、プロジェクトの進展に伴い、同社のエネルギー関連事業（特殊輸送および産業輸送）も恩恵を受けると見ています」とギブソン氏は付け加えた。
Price: $19.94, Change: $+0.50, Percent Change: +2.57%
National Australia Bank (ASX:NAB) shares were down about 1% in recent Monday trade following a Friday settlement with the Finance Sector Union of Australia to resolve court proceedings related to excessive additional working hours for employees.The settlement, reached on a without-admissions basis through mediation, includes the establishment of a health, safety, and well-being framework to mitigate the risks linked to working additional hours, and calls for greater oversight of such risks.The union and the bank said in a joint statement that they are "committed to continuing to work together to ensure fair and sustainable outcomes for all [National Australia Bank] employees."
Clinuvel Pharmaceuticals (ASX:CUV) said the US Food and Drug Administration (FDA) removed a requirement for a post-authorization phase one study on cardiac repolarization in relation to its Scenesse implant upon reviewing its long-term safety profile, according to a Monday filing with the Australian bourse.Scenesse is used to treat patients with erythropoietic protoporphyria, a disease that causes intolerance to light.The FDA concluded that the study was no longer needed since it would not yield valuable safety information, the filing said.
XRF Scientific (ASX:XRF) has completed the acquisition of the combustion gas analysis business from Bruker AXS, according to a Monday Australian bourse filing.The company entered a binding agreement to acquire the combustion gas analysis business for $4 million upfront plus a potential $1 million earnout based on 7% of net revenue over three years, an earlier filing showed.